Tag: hematologic oncology innovations

Home / hematologic oncology innovations

Categories

NMPA Approves FUCASO: Multiple Myeloma Treatment In China

FUCASO treatment in China The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA's approval marks a turning point in China's fight against multiple myeloma. Th...
hematologic-oncology-innovations

Scan the code